Amylyx Pharmaceuticals (AMLX) — Entry Risk Score

Stock · re-scored every trading day · data as of 2026-11-12

81
on a 30–98 scale
BUY
$29.86last close
-3score vs prior day
81–98range since 10-12
+8.7%price since 10-12

The entry score measures one thing: how far Amylyx Pharmaceuticals's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.

On 2026-11-12, Amylyx Pharmaceuticals's price sits 0.70 ATR above its 20-day average ($28.74); it trades above its 200-day average ($20.72); its 14-day RSI is 54; it has moved +13.36% over 20 sessions; our regime filter classifies it as a strong uptrend.

Falling-knife flag: this Buy Zone score comes on top of a -24.71% decline over roughly 60 sessions. In our own data that pattern has swung harder than other Buy Zone names in both directions. See the audit.

Is Amylyx Pharmaceuticals (AMLX) a buy right now?

Amylyx Pharmaceuticals scores 81/98 (Buy) as of 2026-11-12; it is 24.7% below its 52-week high of $39.66; it is above its 200-day average; it moved +1.22% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. It also carries a falling-knife flag (down 24.71% over ~60 sessions). Not investment advice.

Score history

80 60

Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.

DateScoreΔClose
2026-11-1281-3$29.86
2026-11-0684-4$29.50
2026-11-0588+4$27.62
2026-11-0484+0$29.40
2026-11-0384-1$29.20
2026-11-0285-1$28.04
2026-10-2986-3$28.68
2026-10-2889+1$28.07
2026-10-2788-10$28.30
2026-10-2698+3$27.09
2026-10-2395+7$27.20
2026-10-2288+2$28.57

Related stocks

See today's full rankings + entry plan for AMLX →

Get the Sunday Brief

One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.